重要性是模型对已发布报道给出的 1–5 分，不是对市场的预测。
已排定事件行上的影响是公司显著度层级（高/中由图谱中心度与规模判定；低仅用于人工整理的次要事件），不是对波动幅度的预测。
标记为已确认的财报日期，是 Yahoo Finance 认定由公司确认的；预估表示尚未公布。未加标记的行没有可查的出处记录。
经济数据发布属于宏观、不归属任何产业，因此在任何视图下都会保留。没有数值的发布表示尚未公布，页面会直说，而不是显示为零。
涵盖被追踪公司的即将到来的事件；已过去的事件会归档，并在可得时补上结果——这些结果都经人工整理并附引用，绝不杜撰。没有结果的历史行会显示“结果待定”。
解禁或指数调整的行会多出一行算术——将变得可卖出的股数，或指数基金必须买入的股数，以占流通股的比例表示——依据招股说明书或指数编制方法读出，两个数字都在该行注明出处。它陈述的是机制，不是价格走势。由 IPO + 180 天推算出的解禁日期会一直标为预估，直到公司自己说明为止。
10月12日周一 · 今天
10月13日周二
7月30日周四
财报
Madrigal Pharmaceuticals reported "Second-quarter 2026 Rezdiffra (resmetirom) net sales of $364.3 million, representing year-over-year growth of 71%." Management noted Rezdiffra "has already achieved nearly $1.3 billion in trailing-12-month net sales."
大盘 打开原文 ↗
7月29日周三
7月28日周二
财报
Enphase Energy reported "quarterly revenue of $291.9 million in the second quarter of 2026," with "GAAP gross margin of 60.0%" and "non-GAAP gross margin of 46.8%."
大盘 打开原文 ↗
7月27日周一
7月24日周五
合作
GE Aerospace said it and CFM International, "a 50/50 company of GE Aerospace and Safran Aircraft Engines, announced commitments for ~1,800 engines" at the Farnborough Airshow. Announcements included an IndiGo memorandum of understanding for more than 1,000 LEAP-1A engines to power 510 Airbus A320neo Family aircraft, described as the largest single order ever placed for LEAP engines, Philippine Airlines selecting GEnx-1B engines for 15 Boeing 787-10 aircraft, and "AerCap's selection of GEnx-1B engines to power 15 additional Boeing 787 Dreamliners."
Accessibility: Skip TopNav GE Aerospace Wraps Historic Farnborough Airshow Commitment for ~1,800 engines*, including largest LEAP agreement ever with IndiGo July 24, 2026 08:53 ET | Source: GE Aerospace GE Aerospace FARNBOROUGH, England, July 24, 2026 (GLOBE NEWSWIRE) -- GE Aerospace (NYSE: GE) wrapped up the 2026 Farnborough International Airshow with record engine demand, continued momentum across durability and services, and major advances in hybrid electric flight. H. Lawrence Culp, Jr., Chairman and CEO of GE Aerospace, said, “At GE Aerospace, we are focused on delivering for our customer…
大盘 打开原文 ↗
监管
Sanofi announced it will not submit amlitelimab in atopic dermatitis for global regulatory reviews.
大盘 打开原文 ↗
7月23日周四
财报
RTX reported adjusted sales of $24.7 billion, up 16% organically, with adjusted earnings per share up 21% to $1.89 and adjusted segment operating profit up 18% to $3.2 billion. Operating cash flow was $3.5 billion and free cash flow $2.9 billion, with backlog of $289 billion ($170 billion commercial, $119 billion defense). The company raised its full-year outlook.
大盘 打开原文 ↗
